$2.5764
-0.1336[-4.93%]
Last update: 3:03PM Get Real Time Here
BioXcel Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioXcel Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | AM | BTAI | Q1 | -$1.84 | -$0.82 | — | — | $206.00K | $500.00K | — | — | Get Alert |
03/12/2024 | AM | BTAI | Q4 | -$1.95 | -$0.91 | -$0.76 | 16.48% | $238.00K | $710.00K | $376.00K | -47.04% | Get Alert |
11/14/2023 | AM | BTAI | Q3 | -$1.49 | -$1.31 | -$1.58 | -20.61% | $137.00K | $670.00K | $341.00K | -49.10% | Get Alert |
08/14/2023 | AM | BTAI | Q2 | -$1.35 | -$1.75 | -$1.83 | -4.57% | $0.00 | $450.00K | $457.00K | 1.56% | Get Alert |
05/08/2023 | AM | BTAI | Q1 | -$1.12 | -$1.62 | -$1.84 | -13.58% | $0.00 | $500.00K | $206.00K | -58.80% | Get Alert |
03/09/2023 | AM | BTAI | Q4 | -$0.93 | -$1.45 | -$1.95 | -34.48% | $0.00 | $1.25M | $238.00K | -80.96% | Get Alert |
11/10/2022 | AM | BTAI | Q3 | -$0.96 | -$1.35 | -$1.49 | -10.37% | $0.00 | $1.09M | $137.00K | -87.43% | Get Alert |
08/09/2022 | AM | BTAI | Q2 | -$1.11 | -$1.22 | -$1.35 | -10.66% | $0.00 | — | $0.00 | — | Get Alert |
05/09/2022 | AM | BTAI | Q1 | -$1.08 | -$1.15 | -$1.12 | 2.61% | $0.00 | $120.00K | $0.00 | -100.00% | Get Alert |
03/10/2022 | AM | BTAI | Q4 | -$0.87 | -$1.10 | -$0.93 | 15.45% | $0.00 | — | $0.00 | — | Get Alert |
11/10/2021 | AM | BTAI | Q3 | -$1.07 | -$1.05 | -$0.96 | 8.57% | $0.00 | — | $0.00 | — | Get Alert |
08/10/2021 | AM | BTAI | Q2 | -$1.06 | -$1.08 | -$1.11 | -2.78% | $0.00 | — | $0.00 | — | Get Alert |
05/10/2021 | AM | BTAI | Q1 | -$0.79 | -$0.94 | -$1.08 | -14.89% | $0.00 | — | $0.00 | — | Get Alert |
03/11/2021 | AM | BTAI | Q4 | -$0.45 | -$0.96 | -$0.87 | 9.38% | $0.00 | — | $0.00 | — | Get Alert |
11/12/2020 | AM | BTAI | Q3 | -$0.57 | -$0.80 | -$1.07 | -33.75% | $0.00 | — | $0.00 | — | Get Alert |
08/14/2020 | AM | BTAI | Q2 | -$0.54 | -$0.75 | -$1.06 | -41.33% | $0.00 | — | $0.00 | — | Get Alert |
05/12/2020 | AM | BTAI | Q1 | -$0.46 | -$0.59 | -$0.79 | -33.90% | $0.00 | — | $0.00 | — | Get Alert |
03/09/2020 | AM | BTAI | Q4 | -$0.46 | -$0.59 | -$0.45 | 23.73% | $0.00 | — | $0.00 | — | Get Alert |
11/14/2019 | AM | BTAI | Q3 | -$0.31 | -$0.65 | -$0.57 | 12.31% | $0.00 | — | $0.00 | — | Get Alert |
BioXcel Therapeutics (BTAI) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on March 12, 2024 for Q4.
The Actual EPS was $-0.76, which beat the estimate of $-0.91.
The Actual Revenue was $376K, which missed the estimate of $710K.
Browse earnings estimates, EPS, and revenue on all stocks.